These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10362786)

  • 21. [A case of X-linked Alport syndrome with esophageal leiomyomatosis].
    Tang ZL; Yao J; Zhang P; He X; Jia LL; Shi KL; Xia ZK; Gao CL
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):275-277. PubMed ID: 38378292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diffuse leiomyomatosis with genital involvement and Alport syndrome. Report of two cases].
    Le Bras A; David A; Knipping M; Mensier A; Heidet L; Lopes P
    J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):523-8. PubMed ID: 9791580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3rd International Workshop on Alport syndrome.
    Flinter F
    Pediatr Nephrol; 1994 Dec; 8(6):780-2. PubMed ID: 7696125
    [No Abstract]   [Full Text] [Related]  

  • 24. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis.
    Hudson BG; Reeders ST; Tryggvason K
    J Biol Chem; 1993 Dec; 268(35):26033-6. PubMed ID: 8253711
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region.
    Heidet L; Cohen-Solal L; Boye E; Thorner P; Kemper MJ; David A; Larget Piet L; Zhou J; Flinter F; Zhang X; Gubler MC; Antignac C
    Cytogenet Cell Genet; 1997; 78(3-4):240-6. PubMed ID: 9465897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical-pathologic conference in thoracic surgery: Alport syndrome with diffuse leiomyomatosis.
    Cooper J; Patterson GA; Schreiner RJ; Anderson C; Ritter J; O'Sullivan M
    J Thorac Cardiovasc Surg; 1999 Oct; 118(4):760-4. PubMed ID: 10610420
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical spectrum of type IV collagen mutations.
    Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
    Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alport syndrome.
    Kashtan CE; Michael AF
    Kidney Int; 1996 Nov; 50(5):1445-63. PubMed ID: 8914010
    [No Abstract]   [Full Text] [Related]  

  • 29. Pulmonary outcome of Alport syndrome with familial diffuse esophageal leiomyomatosis.
    Livnat G; Best LA; Guralnik L; Bentur L
    Pediatr Pulmonol; 2011 Jun; 46(6):614-6. PubMed ID: 21284097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.
    Kashtan CE
    Medicine (Baltimore); 1999 Sep; 78(5):338-60. PubMed ID: 10499074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alport syndrome and diffuse leiomyomatosis: deletions in the 5' end of the COL4A5 collagen gene.
    Antignac C; Zhou J; Sanak M; Cochat P; Roussel B; Deschênes G; Gros F; Knebelmann B; Hors-Cayla MC; Tryggvason K
    Kidney Int; 1992 Nov; 42(5):1178-83. PubMed ID: 1453602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome.
    Sá MJ; Fieremans N; de Brouwer AP; Sousa R; e Costa FT; Brito MJ; Carvalho F; Rodrigues M; de Sousa FT; Felgueiras J; Neves F; Carvalho A; Ramos U; Vizcaíno JR; Alves S; Carvalho F; Froyen G; Oliveira JP
    J Med Genet; 2013 Nov; 50(11):745-53. PubMed ID: 23958657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal Leiomyomatosis Complicated with Achalasia in a Child With Alport Syndrome.
    Chen JJ; Lien CH; Cheng YJ
    J Pediatr Gastroenterol Nutr; 2021 Oct; 73(4):e105. PubMed ID: 34173796
    [No Abstract]   [Full Text] [Related]  

  • 34. [Molecular genetics of Alport syndrome].
    Yamazaki H; Saito A; Nakagawa Y; Arakawa M
    Nihon Rinsho; 1992 Dec; 50(12):3021-6. PubMed ID: 1491454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alport syndrome associated with diffuse leiomyomatosis: COL4A5-COL4A6 deletion associated with a mild form of Alport nephropathy.
    Mothes H; Heidet L; Arrondel C; Richter KK; Thiele M; Patzer L; Sado Y; Gubler MC; Antignac C; Scheele J
    Nephrol Dial Transplant; 2002 Jan; 17(1):70-4. PubMed ID: 11773466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alport-leiomyomatosis syndrome: an update.
    García-Torres R; Orozco L
    Am J Kidney Dis; 1993 Nov; 22(5):641-8. PubMed ID: 8238008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in type IV collagen genes and Alport phenotypes.
    Tryggvason K
    Contrib Nephrol; 1996; 117():154-71. PubMed ID: 8801044
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunohistologic findings in Alport syndrome.
    Kashtan CE; Kleppel MM; Gubler MC
    Contrib Nephrol; 1996; 117():142-53. PubMed ID: 8801043
    [No Abstract]   [Full Text] [Related]  

  • 39. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors.
    Zhou J; Mochizuki T; Smeets H; Antignac C; Laurila P; de Paepe A; Tryggvason K; Reeders ST
    Science; 1993 Aug; 261(5125):1167-9. PubMed ID: 8356449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse leiomyomatosis in Alport syndrome.
    Cochat P; Guibaud P; Garcia Torres R; Roussel B; Guarner V; Larbre F
    J Pediatr; 1988 Aug; 113(2):339-43. PubMed ID: 3294362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.